文献速递重症综合管理与镇静镇痛

持续/慢性危重症的定义、流行病学与结局:面向临床转化的范围综述

Definitions, epidemiology, and outcomes of persistent/chronic critical illness: a scoping review for translation to clinical practice.
PubMed 文献 · Crit Care · 2024-12-28
一句话结论持续/慢性危重症在全部ICU患者中占11%,脓毒症中占28%、创伤中占24%、COVID-19中占35%,院内死亡27%、1年死亡45%,存活着功能结局差。

该范围综述纳入99项研究,系统梳理持续/慢性危重症(PerCI/CCI)的定义、流行病学与结局。64项研究使用CCI、18项使用PerCI、17项使用其他术语;CCI定义变异大,PerCI定义较一致,最常见为ICU停留≥14天(CCI)和≥10天(PerCI)。Meta分析显示PerCI/CCI在全部ICU患者、脓毒症、创伤、COVID-19中的患病率分别为11%、28%、24%、35%,院内死亡27%、1年死亡45%。存活着功能结局普遍较差,许多需长期照护。

要点

  • 全部ICU患者中PerCI/CCI患病率11%(95%CI 10-12%),脓毒症28%(22-34%)、创伤24%(15-33%)、COVID-19 35%(20-50%)。
  • PerCI/CCI院内死亡率27%(26-29%),1年死亡率45%(32-58%)。
  • CCI与PerCI的患病率分别为17%(16-18%)和18%(16-20%),院内死亡率分别为28%(26-30%)和26%(24-29%)。
  • 最常见定义:CCI为ICU停留≥14天,PerCI为ICU停留≥10天;CCI定义变异大,PerCI定义相对一致。
  • 存活着功能结局普遍较差,许多需长期照护,可用于与患者及家属讨论预后和照护选择。

适用人群与场景

  • 成人危重症患者,涵盖全部ICU患者、脓毒症、创伤和COVID-19人群。
  • 纳入文献为截至2024年5月31日发表的同行评议原创研究,在患者人群、协变量和结局中描述了成人PerCI/CCI。

诊断标准与关键阈值

  • CCI最常见的定义为ICU停留≥14天。
  • PerCI最常见的定义为ICU停留≥10天。

研究设计与关键结果

  • 范围综述遵循PRISMA-ScR指南,检索MEDLINE和Scopus,纳入99项研究。
  • 64项研究使用CCI术语,18项使用PerCI,17项使用其他术语。
  • PerCI/CCI患病率Meta分析:全部ICU患者11%(95%CI 10-12%),脓毒症28%(22-34%),创伤24%(15-33%),COVID-19 35%(20-50%)。
  • CCI与PerCI患病率Meta分析分别为17%(16-18%)和18%(16-20%)。
  • 院内死亡率Meta分析为27%(26-29%),1年死亡率为45%(32-58%)。
  • CCI与PerCI院内死亡率Meta分析分别为28%(26-30%)和26%(24-29%)。
  • 功能结局普遍较差,许多存活着需要长期照护。

证据类型、等级与局限

  • 证据类型:范围综述(scoping review),遵循PRISMA-ScR指南。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,结果强调需要统一的术语和高质量研究来界定PerCI/CCI。
  • 作者认为,结果可为与患者及家属讨论预后和照护选择提供重要信息。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Medical advances in intensive care units (ICUs) have resulted in the emergence of a new patient population-those who survive the initial acute phase of critical illness, but require prolonged ICU stays and develop chronic critical symptoms. This condition, often termed Persistent Critical Illness (PerCI) or Chronic Critical Illness (CCI), remains poorly understood and inconsistently reported across studies, resulting in a lack of clinical practice use. This scoping review aims to systematically review and synthesize the existing literature on PerCI/CCI, with a focus on definitions, epidemiology, and outcomes for its translation to clinical practice.

METHODS: A scoping review was conducted using MEDLINE and Scopus, adhering to the PRISMA-ScR guidelines. Peer-reviewed original research articles published until May 31, 2024 that described adult PerCI/CCI in their definitions of patient populations, covariates, and outcomes were included. Data on definitions, epidemiology, and outcomes were extracted by a data charting process from eligible studies and synthesized.

RESULTS: Ninety-nine studies met the inclusion criteria. Of these studies, 64 used the term CCI, 18 used PerCI, and 17 used other terms. CCI definitions showed greater variability, while PerCI definitions remained relatively consistent, with an ICU stay ≥ 14 days for CCI and ≥ 10 days for PerCI being the most common. A meta-analysis of the prevalence of PerCI/CCI among the denominators of "all ICU patients", "sepsis", "trauma", and "COVID-19" showed 11% (95% confidence interval 10-12%), 28% (22-34%), 24% (15-33%), and 35% (20-50%), respectively. A meta-analysis of in-hospital mortality was 27% (26-29%) and that of one-year mortality was 45% (32-58%). Meta-analyses of the prevalence of CCI and PerCI showed 17% (16-18%) and 18% (16-20%), respectively, and those for in-hospital mortality were 28% (26-30%) and 26% (24-29%), respectively. Functional outcomes were generally poor, with many survivors requiring long-term care.

CONCLUSIONS: This scoping review synthesized many studies on PerCI/CCI, highlighting the serious impact of PerCI/CCI on patients' long-term outcomes. The results obtained underscore the need for consistent terminology with high-quality research for PerCI/CCI. The results obtained provide important information to be used in discussions with patients and families regarding prognosis and care options.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Ohbe H, Satoh K, Totoki T, et al. Definitions, epidemiology, and outcomes of persistent/chronic critical illness: a scoping review for translation to clinical practice. Crit Care. 2024. PMID: 39731183. doi:10.1186/s13054-024-05215-4

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。